Freemont Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$707K Sell
10,000
-1,000
-9% -$74.9K 0.11% 125
2025
Q4
$868K Buy
11,000
+7,300
+197% +$578K 0.15% 107
2025
Q3
$305K Sell
3,700
-27,100
-88% -$2.13M 0.15% 86
2025
Q2
$2.48M Buy
30,800
+7,200
+31% +$556K 0.37% 68
2025
Q1
$1.89M Buy
23,600
+10,700
+83% +$890K 0.62% 50
2024
Q4
$1.06M Hold
12,900
0.46% 67
2024
Q3
$1.06M Hold
12,900
0.52% 60
2024
Q2
$905K Sell
12,900
-63,400
-83% -$4.53M 0.43% 53
2024
Q1
$5.65M Buy
+76,300
New +$5.32M 0.81% 42

Other funds holding MET

Freemont Management's MET Position: Q1 2026 in Review

Freemont Management reduced its MetLife (MET) stake by 9.1% in Q1 2026, selling an estimated $74.9K and leaving 10,000 shares worth $707K. The position accounts for 0.11% of the portfolio, ranked #125.

Freemont Management first reported a position in MET in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.65M in Q1 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Freemont Management held 10,000 shares of MetLife worth $707K as of Q1 2026.
  • Freemont Management sold 1,000 MetLife shares in Q1 2026, an estimated $74.9K.
  • MetLife made up 0.11% of Freemont Management's portfolio in Q1 2026, its #125 holding.
  • Freemont Management first reported a position in MetLife in Q1 2024 and has held it in 9 quarters since.
  • Freemont Management's MetLife position peaked at $5.65M in Q1 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Freemont Management's 13F filing for Q1 2026, filed 6 May 2026.